Current Opinion in Virology

Article	Citations
Structure of SARS-CoV-2 spike protein	120
Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19	111
Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection	98
Recent advances in antiviral drug development towards dengue virus	71
Combating vaccine hesitancy and other 21st century social determinants in the global fight against measles	70
Future considerations for the mRNA-lipid nanoparticle vaccine platform	60
Zoonotic disease and virome diversity in bats	58
Current challenges to virus discovery by meta-transcriptomics	57
Global overview and major challenges of host prediction methods for uncultivated phages	53
Structure and function of SARS-CoV-2 polymerase	51
Coronavirus entry: how we arrived at SARS-CoV-2	50
Animal models for SARS-CoV-2	49
Dengue vaccine development by the year 2020: challenges and prospects	49
A new generation of vaccines based on alphavirus self-amplifying RNA	44
The virome of vector mosquitoes	44
The healthy human virome: from virus–host symbiosis to disease	43
RNA viruses and the cGAS-STING pathway: reframing our understanding of innate immune sensing	42
A structural view of the SARS-CoV-2 virus and its assembly	42
An update on salicylic acid biosynthesis, its induction and potential exploitation by plant viruses	42
Protective and enhancing interactions among dengue viruses 1-4 and Zika virus	41
COVID-19, the first pandemic in the post-genomic era	39
Engineering therapeutic phages for enhanced antibacterial efficacy	39
Cell-to-cell movement of plant viruses via plasmodesmata: a current perspective on potyviruses	39
A microneedle patch for measles and rubella vaccination: a game changer for achieving elimination	39
Recent advances in understanding plant antiviral RNAi and viral suppressors of RNAi	38

Structure, function and assembly of the long, flexible tail of siphophages	34
Viral Z-RNA triggers ZBP1-dependent cell death	34
European regulatory aspects of phage therapy: magistral phage preparations	34
Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?	33
Host cell-intrinsic innate immune recognition of SARS-CoV-2	33
Anti-viral protective capacity of tissue resident memory T cells	32
Dengue mouse models for evaluating pathogenesis and countermeasures	32
Salicylic acid: transport and long-distance immune signaling	32
Risk factors and biomarkers of severe dengue	31
Perspective on taxonomic classification of uncultivated viruses	31
Tombusviruses orchestrate the host endomembrane system to create elaborate membranous replication organelles	31
Measles virus persistence and its consequences	30
Detection of viruses by inflammasomes	29
Influenza D virus	29
Structure, dynamics and phase separation of measles virus RNA replication machinery	28
Entry of influenza A virus into host cells — recent progress and remaining challenges	28
Viral structural proteins as targets for antivirals	27
Mitigation of evolved bacterial resistance to phage therapy	27
Current view and perspectives in viroid replication	26
Rotavirus cell entry: not so simple after all	26
Natural killer cells and unconventional T cells in COVID-19	26
Adenovirus – a blueprint for gene delivery	26
Extracellular vesicles in virus infection and pathogenesis	25
Progress and pitfalls of a year of drug repurposing screens against COVID-19	25
Drug resistance mutations in HIV: new bioinformatics approaches and challenges	25
Critical view on RNA silencing-mediated virus resistance using exogenously applied RNA	23
Measles virus in cancer therapy	23
Animal morbilliviruses and their cross-species transmission potential	23
Digital phagograms: predicting phage infectivity through a multilayer machine learning approach	22
Immune system control of hepatitis C virus infection	22
Mapping the diverse structural landscape of the flavivirus antibody repertoire	22
Proteases and variants: context matters for SARS-CoV-2 entry assays	22
Animal models of SARS-CoV-2 transmission	22
Hepatitis B virus–host interactions and novel targets for viral cure	22
Molecular dynamics of the viral life cycle: progress and prospects	21
Principles of epithelial homeostasis control during persistent human papillomavirus infection and its deregulation at the cervical transformation zone	21
Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy	21
Phage banks as potential tools to rapidly and cost-effectively manage antimicrobial resistance in the developing world	21
Rapid diagnostic tests to address challenges for global measles surveillance	21
Tissues: the unexplored frontier of antibody mediated immunity	21
Nucleic acid-mediated PAMP-triggered immunity in plants	21
R gene mediated defense against viruses	20
Measles Resurgence and Drug Development	20
Epigenetic control of the Epstein-Barr lifecycle	20
Cytomegalovirus as an immunomodulator across the lifespan	20
Targeting of viral RNAs by Upf1-mediated RNA decay pathways	19
Measles pathogenesis, immune suppression and animal models	19
Development of plant-made monoclonal antibodies against viral infections	19
Phage therapy for secondary bacterial infections with COVID-19	19
Historical discourse on the development of the live attenuated tetravalent dengue vaccine candidate TV003/TV005	19

Revisiting an old friend: new findings in alphavirus structure and assembly	19
The long and winding road: human papillomavirus entry and subcellular trafficking	18
UPR signaling at the nexus of plant viral, bacterial, and fungal defenses	18
An overview of the current state of phage therapy for the treatment of biofilm-related infections	18
Measles immunity and immunosuppression	18
Evolution of the interferon response: lessons from ISGs of diverse mammals	18
The gut virome in inflammatory bowel diseases	18
Dengue virus infection and Nrf2 regulation of oxidative stress	17
Antiviral immunity triggered by infection-induced host transposable elements	17
Unresolved questions in the zoonotic transmission of MERS	17
Rhabdoviruses as vectors for vaccines and therapeutics	17
Remdesivir for the treatment of Covid-19: the value of biochemical studies	17
Broadly neutralizing antibodies against HIV-1 and concepts for application	17
Assembly of the virome in newborn human infants	17
Bat virome research: the past, the present and the future	16
Structures of the tailed bacteriophages that infect Gram-positive bacteria	16
The enigmatic roles of Anelloviridae and Redondoviridae in humans	16
Human genetic and immunological dissection of papillomavirus-driven diseases: new insights into their pathogenesis	16
Cryo-electron microscopy of nodavirus RNA replication organelles illuminates positive-strand RNA virus genome replication	16
Interplay between ABA signaling and RNA silencing in plant viral resistance	15
The influence of microbiota-derived metabolites on viral infections	15
Emerging technologies in the study of the virome	15
Shopping for phages? Unpacking design rules for therapeutic phage cocktails	15
Advances in human monoclonal antibody therapy for HBV infection	15
The surface glycoproteins of hantaviruses	14
Virus genomics: what is being overlooked?	14
Seek and hide: the manipulating interplay of measles virus with the innate immune system	14
Endocytosis of Bacteriophages	14
Immunotherapy and therapeutic vaccines for chronic HBV infection	14
Fighting viruses with computers, right now	14
Innate immunity and HBV persistence	14
Virus–host protein interactions as footprints of human cytomegalovirus replication	14
The remarkable viral portal vertex: structure and a plausible model for mechanism	13
Virion structures and genome delivery of honeybee viruses	13
Immune–bacteriophage interactions in inflammatory bowel diseases	13
Microbiota as a potentially-modifiable factor influencing COVID-19	13
Progress and prospects of the healthy human gut virome	13
Bioinformatics of virus taxonomy: foundations and tools for developing sequence-based hierarchical classification	13
Immunodominance complexity: lessons yet to be learned from dominant T cell responses to SARS-COV-2	13
Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccination	13
The origin of Human Papillomavirus (HPV) — induced cervical squamous cancer	12
Antigenic evolution of SARS coronavirus 2	12
Roles of small RNAs in the establishment of tolerant interaction between plants and viruses	12
Seeing and touching adenovirus: complementary approaches for understanding assembly and disassembly of a complex virion	12
The enigma of picobirnaviruses: viruses of animals, fungi, or bacteria?	12
SARS-CoV-2 vaccines — the biggest medical research project of the 21st century	12
Mutational escape from cellular immunity in viral hepatitis: variations on a theme	12
Broadly neutralizing antibodies against COVID-19	11
Arms race between rice and viruses: a review of viral and host factors	11
Fruit bats as natural reservoir of highly pathogenic henipaviruses: balance between antiviral defense and viral tolerance	11
Quantitative measures of within-host viral genetic diversity	11
SnRK1: a versatile plant protein kinase that limits geminivirus infection	11
Hepatitis B virus e antigen and viral persistence	11
Structural and dynamic asymmetry in icosahedrally symmetric virus capsids	10
Cytotoxicity in Epstein Barr virus specific immune control	10
Fishing for phages in metagenomes: what do we catch, what do we miss?	10
Hepatitis C virus and intracellular antiviral response	10
Potential of plasmid only based reverse genetics of rotavirus for the development of next-generation vaccines	10
Teaching old dogmas new tricks: recent insights into the nuclear import of HIV-1	10
Viral–host interactions during splicing and nuclear export of influenza virus mRNAs	10
Natural killer cell responses to emerging viruses of zoonotic origin	10
HIV persistence: silence or resistance?	10
T cell responses during HBV and HCV infections: similar but not quite the same?	10
The morphogenesis of different giant viruses as additional evidence for a common origin of Nucleocytoviricota	9
Flavivirus–host interactions: an expanding network of proviral and antiviral factors	9
Broad neutralizing antibody-based strategies to tackle influenza	9
Non-structural protein 5 (NS5) as a target for antiviral development against established and emergent flaviviruses	9
Tools for the targeted genetic modification of poxvirus genomes	9
Reverse genetics approaches: a novel strategy for African horse sickness virus vaccine design	9
Structural perspectives on HCV humoral immune evasion mechanisms	9
Plant negative-stranded RNA virus biology and host interactions revitalized by reverse genetics	9
Understanding T cell aging to improve anti-viral immunity	9
The journey of herpesvirus capsids and genomes to the host cell nucleus	9
Effects of a changing environment on the defenses of plants to viruses	9
Bacteriophage T4 as a nanovehicle for delivery of genes and therapeutics into human cells	8
Mapping conformational epitopes by NMR spectroscopy	8
Recent progress in development of monoclonal antibodies against human cytomegalovirus	8
Structural characteristics of measles virus entry	8
Immunity to acute virus infections with advanced age	8
Know your enemy and know yourself – the case of SARS-CoV-2 host factors	8

The female reproductive tract virome: understanding the dynamic role of viruses in gynecological health and disease	8
Time to ‘Mind the Gap’ in novel small molecule drug discovery for direct-acting antivirals for SARS-CoV-2	8
Microbiota-immune system interactions and enteric virus infection	8
The importance of viral and cellular factors on flavivirus entry	8
The road to effective and accessible antibody therapies against Ebola virus	8
The biology of papillomavirus PDZ associations: what do they offer papillomaviruses?	8
Virus structure and structure-based antivirals	8
Advancing therapies for viral infections using mechanistic computational models of the dynamic interplay between the virus and host immune response	8